Double positive (TIGIT+CTLA-4+) (IR-9) and triple positive (TIGIT+CTLA-4+TIM-3+) (IR-12) were highest among PD1+CD28+ T cells in periphery and did not increase in the tumor (Fig. 5C). The gene discussed is CD28; the disease is neoplasm.